GenMont Biotech Incorporation (TPE:3164)

TPE:3164 Revenue

GenMont Biotech Incorporation had revenue of 89.17M TWD in the quarter ending March 31, 2026, a decrease of -10.34%. This brings the company's revenue in the last twelve months to 390.95M, up 6.12% year-over-year. In the year 2025, GenMont Biotech Incorporation had annual revenue of 401.23M with 4.11% growth.

• Revenue (ttm): 390.95M
• Revenue Growth: +6.12%
• P/S Ratio: 3.83
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1.50B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	401.23M	15.86M	4.11%
Dec 31, 2024	385.37M	67.36M	21.18%
Dec 31, 2023	318.02M	-50.53M	-13.71%
Dec 31, 2022	368.55M	-59.38M	-13.88%
Dec 31, 2021	427.93M	102.74M	31.59%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 9, 2026

Data Sources Report a data error